Skip to main content
. 2023 May 2;26(8):1626–1633. doi: 10.1017/S1368980023000848

Table 3.

Associations between quartiles of UPF consumption (in servings/d) and obesity indicators by diabetes status in the CACTI cohort followed up for over 14 years *

T1DM Non-diabetic controls
Q2 Q3 Q4 Q2 Q3 Q4
β se β se β se β se β se β se
Weight (kg)
Model 1 0·61 0·97 1·44 1·20 4·19 1·23 0·23 0·81 2·32 0·89 3·74 1·22
Model 2 0·64 0·97 1·46 1·22 3·08 1·20 −0·17 0·75 1·32 0·82 3·13 1·21
Model 3 0·65 0·97 1·47 1·22 3·11 1·21 −0·18 0·74 1·30 0·82 3·08 1·27
Model 4 0·36 1·01 1·21 1·27 3·07 1·27 −0·08 0·76 1·13 0·80 3·36 1·27
WC (cm)
Model 1 1·42 1·25 2·63 1·44 4·15 1·45 2·04 1·08 2·64 1·15 5·04 1·20
Model 2 2·06 1·13 2·38 1·37 3·37 1·40 1·30 0·93 1·61 1·09 3·30 1·14
Model 3 2·13 1·13 2·48 1·37 3·56 1·43 1·39 0·93 1·33 1·10 3·68 1·21
Model 4 2·18 1·23 2·04 1·49 2·89 1·59 1·46 0·93 1·12 1·07 3·80 1·19
BMI (kg/m2)
Model 1 0·35 0·34 0·43 0·40 1·07 0·42 0·11 0·28 0·77 0·33 1·17 0·41
Model 2 0·43 0·32 0·71 0·40 0·97 0·38 0·02 0·26 0·59 0·30 1·04 0·41
Model 3 0·45 0·32 0·73 0·40 1·02 0·39 0·03 0·26 0·60 0·30 1·07 0·43
Model 4 0·42 0·33 0·71 0·40 1·02 0·40 0·07 0·26 0·54 0·30 1·15 0·43
Overweight
Model 1 0·07 0·25 −0·16 0·23 0·11 0·23 0·06 0·18 0·17 0·16 0·65 0·21
Model 2 0·13 0·25 −0·17 0·25 0·01 0·24 0·12 0·19 0·18 0·19 0·62 0·23
Model 3 0·17 0·27 −0·13 0·27 0·02 0·26 0·13 0·19 0·21 0·19 0·69 0·24
Model 4 0·19 0·27 −0·14 0·27 0·05 0·27 0·12 0·19 0·22 0·19 0·70 0·25
Obesity
Model 1 0·14 0·33 0·64 0·31 0·44 0·28 0·04 0·22 0·29 0·21 0·27 0·26
Model 2 0·25 0·36 0·71 0·33 0·40 0·31 −0·03 0·24 0·27 0·22 0·25 0·26
Model 3 0·28 0·36 0·75 0·34 0·49 0·35 −0·04 0·24 0·24 0·22 0·18 0·27
Model 4 0·32 0·36 0·66 0·35 0·34 0·36 0·01 0·25 0·27 0·23 0·21 0·28

UPF: ultra-processed food; Q: quartiles; T1DM: type 1 diabetes mellitus; WC: waist circumferences.

*

Generalised estimating equations were used to measure parameter estimates and se of obesity indicators. Q1 is reference category. Model 1 was unadjusted model. Model 2 adjusted for sex, age, race, education, smoking status, physical activity, and duration of follow-up. Model 3 is model 2 further adjusted for total energy intake. Model 4 is model 3 further adjusted for diabetes duration, antihypertensive and lipid-lowering drugs for T1DM; antihypertensive and lipid-lowering drugs for non-diabetic control.

Significant difference at P < 0·05 (bold).